Edition:
United States

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

24.40USD
20 Jul 2018
Change (% chg)

$-0.11 (-0.45%)
Prev Close
$24.51
Open
$24.51
Day's High
$24.82
Day's Low
$24.32
Volume
125,472
Avg. Vol
178,096
52-wk High
$34.98
52-wk Low
$13.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 14.18 -0.401
FY 2017 Dec '17 27.07 -0.653
Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 18.10 31.40 8.00 --
Quarter Ending Dec-18 7 19.00 34.00 8.00 --
Year Ending Dec-18 7 70.22 104.00 38.20 61.29
Year Ending Dec-19 7 67.17 104.00 0.00 75.37
Earnings (per share)
Quarter Ending Sep-18 8 -0.37 0.06 -0.78 --
Quarter Ending Dec-18 8 -0.46 0.08 -0.99 --
Year Ending Dec-18 7 -1.57 -0.38 -2.76 -1.29
Year Ending Dec-19 8 -2.44 -0.91 -4.14 -2.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 217.69 33.34
P/E High - Last 5 Yrs. -- 284.50 47.12
P/E Low - Last 5 Yrs. -- 96.76 24.95
Beta -- 0.76 0.81
Price to Sales (TTM) 12.88 256.17 8.11
Price to Book (MRQ) 19.12 21.19 4.23
Price to Tangible Book (MRQ) 20.26 27.03 6.21
Price to Cash Flow (TTM) -- 128.89 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.39
Payout Ratio(TTM) -- 84.35 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 21.72 33.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago 203.00 147.14 12.32
Sales - 5 Yr. Growth Rate -- 30.77 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -77.40 -79.61 48.99
EPS (TTM) vs TTM 1 Yr. Ago -43.32 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.97
Capital Spending - 5 Yr. Growth Rate -- 42.60 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 5.27 6.63 3.63
LT Debt to Equity (MRQ) 0.00 24.46 13.08
Total Debt to Equity (MRQ) 0.00 28.66 17.18
Interest Coverage (TTM) -- -154.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.90 55.23
Gross Margin - 5 Yr. Avg. -- 53.43 53.18
EBITD Margin (TTM) -69.65 -- --
EBITD - 5 Yr. Avg -- -182.15 15.61
Operating Margin (TTM) -71.84 -964.42 -0.70
Operating Margin - 5 Yr. Avg. -- -195.77 10.75
Pre-Tax Margin (TTM) -67.09 -858.38 1.18
Pre-Tax Margin - 5 Yr. Avg. -- -200.51 10.87
Net Profit Margin (TTM) -102.54 -849.10 -2.12
Net Profit Margin - 5 Yr. Avg. -- -198.30 7.23
Effective Tax Rate (TTM) -- 14.86 20.83
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 806,011 23,539,371 740,084,415
Net Income/Employee (TTM) -826,467 -1,115,845 86,307,671
Receivable Turnover (TTM) 424.95 17.88 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.27 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -27.43 -2.23 10.36
Return on Assets - 5 Yr. Avg. -- 2.95 11.03
Return on Investment (TTM) -33.98 -3.65 13.18
Return on Investment - 5 Yr. Avg. -- 2.79 14.26
Return on Equity (TTM) -123.20 -5.62 15.09
Return on Equity - 5 Yr. Avg. -- -4.53 15.57
  1 Year 3 Year 5 Year
Sales % 376.12 141.63 --
EPS (TTM) % -13.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.73 -2.40 53 45
13 Week -9.66 -13.91 35 62
26 Week -4.50 -4.21 54 69
52 Week 82.23 60.87 83 85
YTD 15.59 10.30 66 86
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.51%
# of Holders: 206
Total Shares Held: 30,587,469
3 Mo. Net Change: 245,180
# New Positions: 7
# Closed Positions: 5
# Increased Positions: 15
# Reduced Positions: 11
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.